Form 4: Aadi Bioscience Executive Receives Stock Grant
Insider Transaction (Form 4)
Margaret Dugan, Chief Medical Officer of Aadi Bioscience, Inc., reported multiple transactions in common stock on September 15, 2026.
Summary
- Grant/award: acquired 81,250 Stock Option (right to buy) on September 15, 2026; holds 81,250 after (Direct).
- Grant/award: acquired 81,250 Restricted Stock Units on September 15, 2026; holds 81,250 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Margaret Dugan — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Grant/award | Stock Option (right to buy) | 81,250 | — | — | 81,250 |
| 2026-09-15 | Grant/award | Restricted Stock Units | 81,250 | — | — | 81,250 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Grant/award (81,250 shares) |
| 2026-09-15 | Grant/award (81,250 shares) |
Keywords
insider transaction, Form 4, WHWK, Whitehawk Therapeutics, Inc., neutral, Margaret Dugan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.